131.69 USD
↗ 0.90 (0.69%)AT CLOSE (03:59 PM EDT)
Insulet Corporation
PODDNASDAQ • USD
130.65
↘ 1.04 (0.79%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
130.65
↘ 1.04 (0.79%)
Market: CLOSED
PODD is currently priced at $131.69. PODD shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Strong Sell". This is driven by a robust Altman Z-Score, exceptional Return on Equity (26.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, PODD trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 2, 2026.
Open?$131.83
High?$132.53
Low?$128.01
Prev. Close?$130.79
Volume?3.2M
Avg. Volume?1.8M
VWAP?$131.20
Rel. Volume?1.82x
Bid / Ask
Bid?$128.24 × 100
Ask?$132.25 × 500
Spread?$4.01
Midpoint?$130.25
Valuation & Ratios
Market Cap?9.1B
Shares Out?69.4M
Float?69.0M
Float %?99.6%
P/E Ratio?24.34
P/B Ratio?6.42
EPS?$5.41
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Themes
Employees
5.4K
Market Cap
9.1B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2007-05-15
Address
100 NAGOG PARK
ACTON, MA 01720
Phone: 978-600-7000
ACTON, MA 01720
Phone: 978-600-7000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?99
Momentum?80
Short Sent.?55
Piotroski F-Score?6/9Mixed
Altman Z-Score?5.28Safe
Confidence?69%Moderate
Short InterestElevated
Short % of Float?7.37%Elevated
Short Interest?5.1M
Days to Cover?3.2
Free Float69.0M
Avg Daily Volume1.6M
Settlement Date2026-09-15
Financial Health
Current Ratio?2.48Strong
Quick Ratio?1.83Adequate
Cash Ratio?0.72Adequate
Debt/Equity?0.67Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score72/100
P/E?24.3FAIR▾
Peers100
S&P49
P/B?6.42FAIR▾
Peers100
S&P29
P/S?2.99CHEAP▾
Peers100
S&P51
P/FCF?32.3FAIR▾
Peers100
S&P25
EV/EBITDA?15.5FAIR▾
Peers100
S&P47
EV/Sales?3.13FAIR▾
Peers100
S&P59
Returns & Efficiency
ROE?26.4%STRONG▾
Peers50
S&P76
ROA?11.9%STRONG▾
Peers50
S&P80
Cash Flow & Enterprise
FCF?$282.5M
Enterprise Value?$9.5B
Fundamentals ratios updated end of day